Jon OggStocks were holding on to small gains on Tuesday even after weaker sentiment was reported out of Europe. It looks as though investors have decided they can now shop around for…
ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will change during…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Thursday, July 17, 2014. They include AIG, Intel, eBay, EOG Resources, PetSmart and Time Warner.
courtesy of WynnResorts.comThe stock market looks wobbly and that may be starting to make many investors nervous. While in the short-term we may be looking at a correction, the long-term prospects for…
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Wednesday, April 23, 2014. They include Allergan, Galmed Pharmaceuticals, GM, Sirius XM and SunPower.
In a new research report from Deutsche Bank that looks at how the market sets up for the rest of the year, the firm has a list of the 25 largest U.S.…
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off that may provide investors some incredible outsized gains over the rest of…
thinkstockApril 16, 2014: Markets opened higher on Wednesday with shares getting a boost in midmorning from the report on crude oil and gasoline stockpiles. The midafternoon release of the Fed’s Beige Book…
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress hit the sector hard. This may be a…
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In a new research report, Cowen highlights upcoming catalysts that could send some…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, January 17.
Jim Henderson, via Wikimedia CommonsThe 2013 annual Nasdaq rebalance occurs on the close Friday December 20 (triple witching date as well as rebalance date for other indices in the U.S.). During this…
Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which stocks they should still buy and which stocks they should sell or…
ThinkstockBiotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for the stocks…
ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share).…
